Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Thyroid Diseases 1Pituitary Neoplasms 1Pituitary Diseases 1Hypothyroidism 1

Interventions

pasireotide 4Cabergoline 3Surgical Procedures, Operative 2Propofol 2Octreotide 2Human Growth Hormone 2pegvisomant 1entinostat 1corticorelin ovine 1Yoga 1Thyrotropin-Releasing Hormone 1Surveys and Questionnaires 1Supine Position 1Sevoflurane 1Resistance Training 1Radiotherapy 1Radiosurgery 1Photochemotherapy 1Nivolumab 1Neurosurgical Procedures 1Lapatinib 1Ipilimumab 1Ibuprofen 1Hydrocortisone 1Growth Hormone 1Dosage Forms 1Dihematoporphyrin Ether 1Dexamethasone 1Desflurane 1Continuous Glucose Monitoring 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pituitary Neoplasms × Thyrotropin-Releasing Hormone × Clear all
NCT00054756 2018-08-08

Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
96 enrolled 6 charts
EndocrineHead & Neck

Hypothyroidism, Pituitary Diseases, Pituitary Neoplasms, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡